KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Amortization - IntangiblesConsolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRestructuring CostsRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Pacira BioSciences (PCRX) Revenue: 2009-2024

Historic Revenue for Pacira BioSciences (PCRX) over the last 16 years, with Dec 2024 value amounting to $701.0 million.

  • Pacira BioSciences' Revenue rose 6.49% to $179.5 million in Q3 2025 from the same period last year, while for Sep 2025 it was $716.8 million, marking a year-over-year increase of 3.14%. This contributed to the annual value of $701.0 million for FY2024, which is 3.85% up from last year.
  • Pacira BioSciences' Revenue amounted to $701.0 million in FY2024, which was up 3.85% from $675.0 million recorded in FY2023.
  • Over the past 5 years, Pacira BioSciences' Revenue peaked at $701.0 million during FY2024, and registered a low of $429.6 million during FY2020.
  • Over the past 3 years, Pacira BioSciences' median Revenue value was $675.0 million (recorded in 2023), while the average stood at $680.9 million.
  • Data for Pacira BioSciences' Revenue shows a peak YoY rose of 26.04% (in 2021) over the last 5 years.
  • Yearly analysis of 5 years shows Pacira BioSciences' Revenue stood at $429.6 million in 2020, then increased by 26.04% to $541.5 million in 2021, then grew by 23.14% to $666.8 million in 2022, then rose by 1.22% to $675.0 million in 2023, then grew by 3.85% to $701.0 million in 2024.